Table 1 Clinical characteristics of research subjects
Normal | Asthma | ||
|---|---|---|---|
# of Subjects | 7 | 7 | |
Age (years) | 38.3±5.4 | 38.4±3.5 | P=NS |
Gender (M:F) | (2:5) | (2:5) | |
Asthma severity (mild/moderate vs. severe) | n/a | 5/2 | |
Positive allergy skin testa | 2/7 | 6/7 | |
Positive skin test to Dermatophagoides farinae | 1/7 | 6/7 | |
FEV1 (liters) | 3.51±0.20 | 2.63±0.14 | P=0.002 |
FEV1 (% predicted) | 103±2.79 | 82.7±4.67 | P=0.027 |
Blood eosinophils (k μl−1) | 0.137±0.04 | 0.223±0.05 | P=NS |
Blood eosinophils (%) | 2.34±0.62 | 3.46±0.80 | P=NS |
IgE (IU ml−1) | 59.17±25.38 | 3651±3238 | P=NS |
FeNO (ppb) | 19.1±7.4 | 34.2±10.2 | P=NS |
Oral corticosteroids (%) | 0 | 0 | |
Inhaled corticosteroids (%) | 0 | 71% | |
BALF macrophages (× 104 per ml) | 1,077±253 | 808±247 | P=NS |
BALF eosinophils (× 104 per ml) | 0 | 14±6 | P=NS |
BALF lymphocytes (× 104 per ml) | 118±51 | 168±89 | P=NS |
BALF neutrophils (× 104 per ml) | 65±17 | 81±22 | P=NS |